While the impact of the IRA on the pharmaceutical industry cannot yet be fully determined, it is likely to be significant.
All entries for: OmniAb
April 29, 2025
OmniAb
Neutral Outlook
Emeryville, CA
51-200 employees
Disease Area: Immune Diseases, Multiple, Neurological Diseases, Oncology
Drug Type: Biologic